A Phase II Study of Intraperitoneal 32p and Vaginal Brachytherapy in the Treatment of Papillary Serous and Clear Cell Adenocarcinoma of the Endometrium

Abstracts/Posters/Presentations:

• Achilles J. Fakiris, Higinia R. Cardenes, David H. Moore, Shailaja R. Reddy, Katherine Y. Look, Constantin T. Yiannoutsos, Marcus E. Randall. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: A Phase II Hoosier Oncology Group GYN97-1 study. Accepted at the Society of Gynecologic Oncologists Annual Meeting February 7-11, 2004, San Diego, CA. Gynec Oncol, 92(2004); 439.

Manuscripts/Articles:

• Achilles J. Fakiris, Higinia R. Cardenes, David H. Moore, Shailaja R. Reddy, Katherine Y. Look, Constantin T. Yiannoutsos, Marcus E. Randall. Indiana University School of Medicine, Indianapolis, IN. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: A Phase II Hoosier Oncology Group Study GYN97-1. Gynecologic Oncology, 2005; 96: 818-823. See abstract.